Senior insider sale
Chief Development Officer at CRINETICS PHARMACEUTICALS, INC. — senior position signals high conviction
$1.17M
25K shares
What this filing means
PIZZUTI DANA plans to sell 25K shares of CRINETICS PHARMACEUTICALS, INC. valued at approximately $1.17M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/2/2026ACC: 0001950047-26-000824
Officer· Chief Development Officer
Since Sep 2022
25K
Shares to sell
$1.17M
Approx. market value
10K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
2/2/2026
10KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/2/2026 | Exercise of Stock Options Cash | 10K | — |
| Total | 10K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
5K
Market value
$232.6K
1/2/2026
—Completed
Units to sell
5K
Market value
$225.1K
12/1/2025
—Completed
Units to sell
5K
Market value
$213.3K
11/3/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
10K
Market value
$499.4K
2/2/2026
Total
Units
25K
Value
$1.17M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/2/2026 | 5K | $232.6K | — | Completed |
12/1/2025 | 5K | $225.1K | — | Completed |
11/3/2025 | 5K | $213.3K | — | Completed |
| Planned — Approximate Date | ||||
2/2/2026 | 10K | $499.4K | NASDAQ | Planned |
| Total | 25K | $1.17M | ||